drugset / Trial / NCT00558649

A Pilot Study to Evaluate the Safety and Immunogenicity of Low Dose Flu Vaccines

NCT00558649

Completed 180 enrolled NanoPass Technologies Ltd
RandomizedParallel-groupSingle-blindPrevention

Summary

The purpose of this study is to determine whether low dose flu vaccines delivered with microneedles into the skin (intradermally) are effective.

Timeline

Start
2007-05
Primary completion
2007-09
Completion
2007-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Influenza Virus Vaccine Vaccine Intravenous

Indications